FDA Launches Effort to Ease Approval Pathway for Biosimilars

MedPage Today) — Federal regulators are trying to make it easier to develop cheaper alternatives to biologics that many Americans depend on to treat autoimmune diseases or cancers.
The FDA said Wednesday it has released guidance to simplify…